The Receptor Tyrosine Kinase AXL is Required at Multiple Steps of the Metastatic Cascade during HER2-positive Breast Cancer Progression
Published: 19 March 2018| Version 1 | DOI: 10.17632/xjwbwrb35k.1
Contributor:
Jean-Francois Côté
Description
Western blots from The Receptor Tyrosine Kinase AXL is Required at Multiple Steps of the Metastatic Cascade during HER2-positive Breast Cancer Progression